A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).

Por um escritor misterioso
Last updated 06 julho 2024
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
/index.php/cjht/article/downlo
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019, Advances in Rheumatology
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
New evidence on the management of spondyloarthritis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial, Trials
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
TNF Inhibitor Therapy, Ankylosing Spondylitis

© 2014-2024 importacioneskab.com. All rights reserved.